Class A · CUSIP 21217B100 · who reports it, how much, and how much it matters to them
23 of the 720 hedge fund managers we track reported shares of Contineum Therapeutics, Inc. (Nasdaq: CTNM) on Form 13F for 30 June 2026. Between them they reported USD 163m. The largest position belongs to Suvretta Capital Management, at USD 47m. The manager with the most riding on it is Great Point Partners, where it is 2.9% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Suvretta Capital Management4 funds on PPLI.com | USD 47m | 0.9% |
| 2 | Balyasny Asset Management25 funds on PPLI.com | USD 25m | 0.0% |
| 3 | Perceptive Advisors6 funds on PPLI.com | USD 21m | 0.3% |
| 4 | Millennium Management6 funds on PPLI.com | USD 15m | 0.0% |
| 5 | Great Point Partners2 funds on PPLI.com | USD 15m | 2.9% |
| 6 | Boxer Capital Management1 fund on PPLI.com | USD 8.1m | 0.6% |
| 7 | Citadel Advisors32 funds on PPLI.com | USD 6.5m | 0.0% |
| 8 | Adage Capital Management1 fund on PPLI.com | USD 5.4m | 0.0% |
| 9 | Boothbay Fund Management2 funds on PPLI.com | USD 3.6m | 0.0% |
| 10 | Sphera Funds Management1 fund on PPLI.com | USD 3m | 0.4% |
| 11 | Casdin Capital3 funds on PPLI.com | USD 2.4m | 0.1% |
| 12 | Eversept Partners3 funds on PPLI.com | USD 2.4m | 0.1% |
| 13 | Marshall Wace LLP84 funds on PPLI.com | USD 1.9m | 0.0% |
| 14 | Verdad Advisers6 funds on PPLI.com | USD 1.3m | 1.3% |
| 15 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 1.1m | 0.0% |
| 16 | Renaissance Technologies13 funds on PPLI.com | USD 1.1m | 0.0% |
| 17 | Acuta Capital Partners2 funds on PPLI.com | USD 1m | 0.7% |
| 18 | Persistent Asset Partners10 funds on PPLI.com | USD 541,000 | 0.2% |
| 19 | Two Sigma Investments35 funds on PPLI.com | USD 497,000 | 0.0% |
| 20 | POINT72 Asset Management17 funds on PPLI.com | USD 423,000 | 0.0% |
| 21 | The Quarry1 fund on PPLI.com | USD 411,000 | 0.0% |
| 22 | Squarepoint Ops7 funds on PPLI.com | USD 192,000 | 0.0% |
| 23 | Engineers Gate Manager1 fund on PPLI.com | USD 180,000 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Great Point Partners | USD 15m | 2.9% |
| 2 | Verdad Advisers | USD 1.3m | 1.3% |
| 3 | Suvretta Capital Management | USD 47m | 0.9% |
| 4 | Acuta Capital Partners | USD 1m | 0.7% |
| 5 | Boxer Capital Management | USD 8.1m | 0.6% |
| 6 | Sphera Funds Management | USD 3m | 0.4% |
| 7 | Perceptive Advisors | USD 21m | 0.3% |
| 8 | Persistent Asset Partners | USD 541,000 | 0.2% |
| 9 | Eversept Partners | USD 2.4m | 0.1% |
| 10 | Casdin Capital | USD 2.4m | 0.1% |
Contineum Therapeutics, Inc. trades under the symbol CTNM on the Nasdaq. Its CUSIP, the code used on Form 13F, is 21217B100.
23 of the 720 hedge fund managers PPLI.com tracks reported Contineum Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Suvretta Capital Management (USD 47m), Balyasny Asset Management (USD 25m), Perceptive Advisors (USD 21m), Millennium Management (USD 15m) and Great Point Partners (USD 15m).
23 managers in our coverage reported it, and between them they run 292 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Great Point Partners, where the position was 2.9% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Contineum Therapeutics, Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.